Market Indices
Sector Heatmap
CADL — Candel Therapeutics, Inc. Common Stock
NasdaqCandel Therapeutics, Inc. Common Stock
- O
- 10.29
- H
- 10.37
- L
- 10.03
- V
- 877.87K
CADL — Latest News & Headlines
19 StoriesWhy CADL Stock Plunged Nearly 15% In After-Hours Trading Today - Stocktwits
Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today Stocktwits
Candel Therapeutics Shares Rise After BofA Upgrade - finance.yahoo.com
Candel Therapeutics Shares Rise After BofA Upgrade finance.yahoo.com
Candel will present findings on lung cancer that progressed despite immunotherapy and recurrent brain cancer. - Stock Titan
Candel will present findings on lung cancer that progressed despite immunotherapy and recurrent brain cancer. Stock Titan
Candel Therapeutics (CADL) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Candel Therapeutics (CADL) Short Interest & Short Float | Updated Sep 2026 MarketBeat
Understanding Momentum Shifts in (CADL) - Stock Traders Daily
Understanding Momentum Shifts in (CADL) Stock Traders Daily
Candel Therapeutics stock jumps on BofA upgrade to buy - Investing.com
Candel Therapeutics stock jumps on BofA upgrade to buy Investing.com
Candel Therapeutics, Inc. (NASDAQ:CADL): When Will It Breakeven? - Moomoo
Candel Therapeutics, Inc. (NASDAQ:CADL): When Will It Breakeven? Moomoo
H.C. Wainwright Remains a Buy on Candel Therapeutics (CADL) - The Globe and Mail
H.C. Wainwright Remains a Buy on Candel Therapeutics (CADL) The Globe and Mail
A director receives 2,189 options instead of quarterly cash pay at Candel Therapeutics (CADL). - Stock Titan
A director receives 2,189 options instead of quarterly cash pay at Candel Therapeutics (CADL). Stock Titan
CADL Slips Despite Encouraging Prostate Cancer Drug Data — Retail Believes Stock Is ‘Clearly A Buy And Hold’ - Stocktwits
CADL Slips Despite Encouraging Prostate Cancer Drug Data — Retail Believes Stock Is ‘Clearly A Buy And Hold’ Stocktwits
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The Manila Times
PRCH,RILY,DOMH,KRT,IDN,BW,MATV,SVRA,TRST,CADL,ULBI,GBLI,GLSI,DLAPQ,NVCT,CRGY | Stock Prices | Quote Comparison - Yahoo Finance - Yahoo! Finance Canada
PRCH,RILY,DOMH,KRT,IDN,BW,MATV,SVRA,TRST,CADL,ULBI,GBLI,GLSI,DLAPQ,NVCT,CRGY | Stock Prices | Quote Comparison - Yahoo Finance Yahoo! Finance Canada
Candel Therapeutics NSCLC Trial: 24.5-Month Median Survival | CADL Stock News - Stock Titan
Candel Therapeutics NSCLC Trial: 24.5-Month Median Survival | CADL Stock News Stock Titan
Candel Therapeutics stock jumps on BofA upgrade to buy By Investing.com - Investing.com UK
Candel Therapeutics stock jumps on BofA upgrade to buy By Investing.com Investing.com UK
Two years later, 80% of evaluable patients had negative prostate biopsies; 63% on placebo. - Stock Titan
Two years later, 80% of evaluable patients had negative prostate biopsies; 63% on placebo. Stock Titan
Candel Therapeutics stock jumps on BofA upgrade to buy By Investing.com - Investing.com India
Candel Therapeutics stock jumps on BofA upgrade to buy By Investing.com Investing.com India
H.C. Wainwright reiterates Candel Therapeutics stock rating on trial data - Investing.com India
H.C. Wainwright reiterates Candel Therapeutics stock rating on trial data Investing.com India
Form 4 Candel Therapeutics Inc For: 2 October By Investing.com - Investing.com Nigeria
Form 4 Candel Therapeutics Inc For: 2 October By Investing.com Investing.com Nigeria
Why is Candel Therapeutics stock surging today? By Investing.com - Investing.com UK
Why is Candel Therapeutics stock surging today? By Investing.com Investing.com UK